150 related articles for article (PubMed ID: 35616097)
1. Dutch National Round Robin Trial on Plasma-Derived Circulating Cell-Free DNA Extraction Methods Routinely Used in Clinical Pathology for Molecular Tumor Profiling.
van der Leest P; Ketelaar EM; van Noesel CJM; van den Broek D; van Boerdonk RAA; Deiman B; Rifaela N; van der Geize R; Huijsmans CJJ; Speel EJM; Geerlings MJ; van Schaik RHN; Jansen MPHM; Dane-Vogelaar R; Driehuis E; Leers MPG; Sidorenkov G; Tamminga M; van Kempen LC; Schuuring E
Clin Chem; 2022 Jul; 68(7):963-972. PubMed ID: 35616097
[TBL] [Abstract][Full Text] [Related]
2. External Quality Assessment on Molecular Tumor Profiling with Circulating Tumor DNA-Based Methodologies Routinely Used in Clinical Pathology within the COIN Consortium.
van der Leest P; Rozendal P; Hinrichs J; van Noesel CJM; Zwaenepoel K; Deiman B; Huijsmans CJJ; van Eijk R; Speel EJM; van Haastert RJ; Ligtenberg MJL; van Schaik RHN; Jansen MPHM; Dubbink HJ; de Leng WW; Leers MPG; Tamminga M; van den Broek D; van Kempen LC; Schuuring E
Clin Chem; 2024 May; 70(5):759-767. PubMed ID: 38484302
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Circulating Cell-Free DNA Extraction Methods for Downstream Analysis in Cancer Patients.
Leest PV; Boonstra PA; Elst AT; Kempen LCV; Tibbesma M; Koopmans J; Miedema A; Tamminga M; Groen HJM; Reyners AKL; Schuuring E
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32414097
[TBL] [Abstract][Full Text] [Related]
4. Multicenter Evaluation of Circulating Cell-Free DNA Extraction and Downstream Analyses for the Development of Standardized (Pre)analytical Work Flows.
Lampignano R; Neumann MHD; Weber S; Kloten V; Herdean A; Voss T; Groelz D; Babayan A; Tibbesma M; Schlumpberger M; Chemi F; Rothwell DG; Wikman H; Galizzi JP; Riise Bergheim I; Russnes H; Mussolin B; Bonin S; Voigt C; Musa H; Pinzani P; Lianidou E; Brady G; Speicher MR; Pantel K; Betsou F; Schuuring E; Kubista M; Ammerlaan W; Sprenger-Haussels M; Schlange T; Heitzer E
Clin Chem; 2020 Jan; 66(1):149-160. PubMed ID: 31628139
[TBL] [Abstract][Full Text] [Related]
5. Detection and Monitoring of Tumor-Derived Mutations in Circulating Tumor DNA Using the UltraSEEK Lung Panel on the MassARRAY System in Metastatic Non-Small Cell Lung Cancer Patients.
Leest PV; Janning M; Rifaela N; Azpurua MLA; Kropidlowski J; Loges S; Lozano N; Sartori A; Irwin D; Lamy PJ; Hiltermann TJN; Groen HJM; Pantel K; Kempen LCV; Wikman H; Schuuring E
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686200
[TBL] [Abstract][Full Text] [Related]
6. Optimization of Sources of Circulating Cell-Free DNA Variability for Downstream Molecular Analysis.
Till JE; Black TA; Gentile C; Abdalla A; Wang Z; Sangha HK; Roth JJ; Sussman R; Yee SS; O'Hara MH; Thompson JC; Aggarwal C; Hwang WT; Elenitoba-Johnson KSJ; Carpenter EL
J Mol Diagn; 2021 Nov; 23(11):1545-1552. PubMed ID: 34454115
[TBL] [Abstract][Full Text] [Related]
7. Leveraging the Fragment Length of Circulating Tumour DNA to Improve Molecular Profiling of Solid Tumour Malignancies with Next-Generation Sequencing: A Pathway to Advanced Non-invasive Diagnostics in Precision Oncology?
Underhill HR
Mol Diagn Ther; 2021 Jul; 25(4):389-408. PubMed ID: 34018157
[TBL] [Abstract][Full Text] [Related]
8. Detection of circulating tumor DNA without a tumor-informed search using next-generation sequencing is a prognostic biomarker in pancreatic ductal adenocarcinoma.
Affolter KE; Hellwig S; Nix DA; Bronner MP; Thomas A; Fuertes CL; Hamil CL; Garrido-Laguna I; Scaife CL; Mulvihill SJ; Underhill HR
Neoplasia; 2021 Sep; 23(9):859-869. PubMed ID: 34298235
[TBL] [Abstract][Full Text] [Related]
9. Influence of storage conditions and extraction methods on the quantity and quality of circulating cell-free DNA (ccfDNA): the SPIDIA-DNAplas External Quality Assessment experience.
Malentacchi F; Pizzamiglio S; Verderio P; Pazzagli M; Orlando C; Ciniselli CM; Günther K; Gelmini S
Clin Chem Lab Med; 2015 Nov; 53(12):1935-42. PubMed ID: 25883202
[TBL] [Abstract][Full Text] [Related]
10. Detection of EGFR Mutations in Circulating Tumor DNA (ctDNA) Retrieved from Plasma - Interlaboratory Quality Assessment in the Czech Republic.
Linda Č; Markéta K; Ivana T; Eva P; Milada M; Hana V; Ondřej H; Karolína B; Jiří D; Monika B; Pavel D
Klin Onkol; 2018; 31(5):353-360. PubMed ID: 30541321
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of automated techniques for extraction of circulating cell-free DNA for implementation in standardized high-throughput workflows.
Lehle S; Emons J; Hack CC; Heindl F; Hein A; Preuß C; Seitz K; Zahn AL; Beckmann MW; Fasching PA; Ruebner M; Huebner H
Sci Rep; 2023 Jan; 13(1):373. PubMed ID: 36611077
[TBL] [Abstract][Full Text] [Related]
12. Automated size selection for short cell-free DNA fragments enriches for circulating tumor DNA and improves error correction during next generation sequencing.
Hellwig S; Nix DA; Gligorich KM; O'Shea JM; Thomas A; Fuertes CL; Bhetariya PJ; Marth GT; Bronner MP; Underhill HR
PLoS One; 2018; 13(7):e0197333. PubMed ID: 30044795
[TBL] [Abstract][Full Text] [Related]
13. Critical Factors in the Analytical Work Flow of Circulating Tumor DNA-Based Molecular Profiling.
van der Leest P; Schuuring E
Clin Chem; 2024 Jan; 70(1):220-233. PubMed ID: 38175597
[TBL] [Abstract][Full Text] [Related]
14. Isolation of Cell-Free DNA from Maternal Plasma.
Stray J; Zimmermann B
Methods Mol Biol; 2019; 1885():309-323. PubMed ID: 30506207
[TBL] [Abstract][Full Text] [Related]
15. Interlaboratory evaluation of quality control methods for circulating cell-free DNA extraction.
Devonshire A; Jones G; Gonzalez AF; Kofanova O; Trouet J; Pinzani P; Gelmini S; Bonin S; Foy C
N Biotechnol; 2023 Dec; 78():13-21. PubMed ID: 37730172
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Evaluation of the Factors Affecting Plasma Circulating Cell-Free DNA Levels and Their Application in Diagnosing Nonsmall Cell Lung Cancer.
Chen Z; Zhang S; Li C; Xu C; Zhao J; Miao L
Genet Test Mol Biomarkers; 2019 Apr; 23(4):270-276. PubMed ID: 30986099
[TBL] [Abstract][Full Text] [Related]
17. Comparison of methods for isolation and quantification of circulating cell-free DNA from patients with endometriosis.
Huebner H; Lubrich H; Blum S; Antoniadis S; Lermann J; Ekici A; Fasching PA; Beckmann MW; Ruebner M; Burghaus S
Reprod Biomed Online; 2021 Nov; 43(5):788-798. PubMed ID: 34493460
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of commercial kits for isolation and bisulfite conversion of circulating cell-free tumor DNA from blood.
Kresse SH; Brandt-Winge S; Pharo H; Flatin BTB; Jeanmougin M; Vedeld HM; Lind GE
Clin Epigenetics; 2023 Sep; 15(1):151. PubMed ID: 37710283
[TBL] [Abstract][Full Text] [Related]
19. Reliability of liquid biopsy analysis: an inter-laboratory comparison of circulating tumor DNA extraction and sequencing with different platforms.
Koessler T; Paradiso V; Piscuoglio S; Nienhold R; Ho L; Christinat Y; Terracciano LM; Cathomas G; Wicki A; McKee TA; Nouspikel T
Lab Invest; 2020 Nov; 100(11):1475-1484. PubMed ID: 32616816
[TBL] [Abstract][Full Text] [Related]
20. Performance comparison of commercial kits for isolating and detecting circulating tumor DNA.
Wang M; Huang X; Li X; Guo Q; Xu W; Zhao M; Wang X; Wang L; Lou J
Scand J Clin Lab Invest; 2021 Jul; 81(4):276-281. PubMed ID: 33999736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
